Security · Full coverage
Turkey Opens Antitrust Investigation Into Israeli Pharma Company Teva
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Unrated 2
By חדשות חוץ
First reported by Globes · Aug 26, 2026
What happened
Turkey's Competition Authority has opened an antitrust investigation into Israeli drugmaker Teva over alleged anti-competitive practices related to its Copaxone drug. Teva denies wrongdoing and will cooperate. The probe occurs amid rising Israel-Turkey tensions following an Israeli strike in Syria.
- 01Turkey's Competition Authority investigates Teva for possible antitrust violations since August.
- 02Investigation focuses on market entry barriers and alleged misleading claims about competitors' products.
- 03Teva says probe concerns past issues with Copaxone and denies any misconduct.
- 04Teva commits to cooperating with Turkish regulators during the investigation.
- 05The probe coincides with increased Israel-Turkey tensions after an Israeli airstrike in Syria.
- 06Israeli Defense Minister cites intelligence on Turkish threats as reason for recent military action.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Despite Turkey's Boycott, Some Israeli Companies Keep Trading ThereJun 22, 2026Turkish Textile Tycoon Opens Israeli Company Amid Tax Authority Investigation Over Customs FraudJul 6, 2026Turkey Accused of Using Antisemitism to Prosecute IDF Soldiers5 days agoRussia Strikes Israeli Firm Teva's Warehouses in Ukraine Twice3 days agoTurkey Pushes Interpol Red Notice Against Israeli PM Amid Rising TensionsAug 21, 2026Israel's Competition Authority Investigates Food Giants' Shelf Dominance1 day ago